Company profile

Amphastar Pharmaceuticals, Inc.

AMPH · NASDAQ (Exact normalized legal-name match to SEC CIK 0001297184. Sources: https://clinicaltrials.gov/study/NCT00634517 ; https://data.sec.gov/submissions/CIK0001297184.json Sources: https://clinicaltrials.gov/study/NCT00634517 ; https://data.sec.gov/submissions/CIK0001297184.json Sources: https://clinicaltrials.gov/study/NCT00634517 ; https://data.sec.gov/submissions/CIK0001297184.json Sources: https://clinicaltrials.gov/study/NCT00634517 ; https://data.sec.gov/submissions/CIK0001297184.json Sources: https://clinicaltrials.gov/study/NCT00634517 ; https://data.sec.gov/submissions/CIK0001297184.json Company created by asset-pipeline-v2/ownership-evidence-pass.)

Share price · AMPH

$21.34+4.14 (+24.07%) 3M

close as of 2026-08-18 · 24h delayed · vol 402K

Loading chart…

Prices are end-of-day (EOD), delayed by 24 hours · Unadjusted for historical splits · Data via Databento

Assets

(8 total)

8Total Assets

8Approved

0Phase 3 / Filed

0Phase 1–2 / Early

1Diseases

Showing 8 of 8 assets

		Target & Modality
albuterol (Armstrong Albuterol HFA)	Approved	Beta-2 adrenergic receptorSmall molecule	Asthma
albuterol HFA (Armstrong's)	Approved	Beta-2 adrenergic receptorSmall molecule	Asthma
albuterol HFA (Proventil HFA)	Approved	Beta-2 adrenergic receptorSmall molecule	Asthma
albuterol sulfate (Amphastar)	Approved	Beta-2 adrenergic receptorSmall molecule	Asthma
Albuterol sulfate (Armstrong)	Approved	Beta-2 adrenergic receptorSmall molecule	Asthma
Albuterol Sulfate (Provenetil-HFA)	Approved	Beta-2 adrenergic receptorSmall molecule	Asthma
Primatene Mist	Approved	Adrenergic receptor (non-selective, alpha+beta) · Alpha-1 and beta-1/beta-2 adrenergic receptors · Adrenergic receptors, nonselectiveSmall molecule	Asthma
Proventil	Approved	Beta-2 adrenergic receptorSmall molecule	Asthma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Insider transactions

Research

Unlock insider transactions

Research includes SEC Form 4 insider transactions — filed buys, sells, awards and exercises linked to the underlying filings.

Institutional holders

Research

Unlock institutional holders

Research includes quarterly SEC 13F institutional ownership — top holders, aggregate positions and quarter-over-quarter context.